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ABSTRACT Experiments using bacteriophage (phage) to infect bacterial strains
have helped deﬁne some basic genetic concepts in microbiology, but our under-
standing of the complexity of bacterium-phage interactions is still limited. As the
global threat of antibiotic resistance continues to increase, phage therapy has re-
emerged as an attractive alternative or supplement to treating antibiotic-resistant
bacterial infections. Further, the long-used method of phage typing to classify bacte-
rial strains is being replaced by molecular genetic techniques. Thus, there is a grow-
ing need for a complete understanding of the precise molecular mechanisms under-
pinning phage-bacterium interactions to optimize phage therapy for the clinic as
well as for retrospectively interpreting phage typing data on the molecular level. In
this study, a genomics-based ﬁtness assay (TraDIS) was used to identify all host
genes involved in phage susceptibility and resistance for a T4 phage infecting Shiga-
toxigenic Escherichia coli O157. The TraDIS results identiﬁed both established and
previously unidentiﬁed genes involved in phage infection, and a subset were con-
ﬁrmed by site-directed mutagenesis and phenotypic testing of 14 T4 and 2 T7
phages. For the ﬁrst time, the entire sap operon was implicated in phage suscepti-
bility and, conversely, the stringent starvation protein A gene (sspA) was shown to
provide phage resistance. Identifying genes involved in phage infection and replica-
tion should facilitate the selection of bespoke phage combinations to target speciﬁc
bacterial pathogens.
IMPORTANCE Antibiotic resistance has diminished treatment options for many
common bacterial infections. Phage therapy is an alternative option that was once
popularly used across Europe to kill bacteria within humans. Phage therapy acts by
using highly speciﬁc viruses (called phages) that infect and lyse certain bacterial spe-
cies to treat the infection. Whole-genome sequencing has allowed modernization of
the investigations into phage-bacterium interactions. Here, using E. coli O157 and T4
bacteriophage as a model, we have exploited a genome-wide ﬁtness assay to inves-
tigate all genes involved in deﬁning phage resistance or susceptibility. This knowl-
edge of the genetic determinants of phage resistance and susceptibility can be used
to design bespoke phage combinations targeted to speciﬁc bacterial infections for
successful infection eradication.
Received 30 March 2018 Accepted 27 June
2018 Published 24 July 2018
Citation Cowley LA, Low AS, Pickard D, Boinett
CJ, Dallman TJ, Day M, Perry N, Gally DL, Parkhill
J, Jenkins C, Cain AK. 2018. Transposon
insertion sequencing elucidates novel gene
involvement in susceptibility and resistance to
phages T4 and T7 in Escherichia coli O157. mBio
9:e00705-18. https://doi.org/10.1128/mBio
.00705-18.
Invited Editor Claire M. Fraser, University of
Maryland, School of Medicine
Editor R. John Collier, Harvard Medical School
Copyright © 2018 Cowley et al. This is an
open-access article distributed under the terms
of the Creative Commons Attribution 4.0
International license.
Address correspondence to Lauren A. Cowley,
drlacowley@gmail.com.
RESEARCH ARTICLE
crossm
July/August 2018 Volume 9 Issue 4 e00705-18 ® mbio.asm.org 1
KEYWORDS bacteriophage, Gram-negative bacteria, mutagenesis, transposons,
whole-genome sequencing
Antibiotic resistance poses one of the greatest threats to public health, withtreatment options to reduce levels of mortality and morbidity from bacterial
diseases likely to decrease (1). Thus, alternative treatments that are successful in killing
resistant bacteria are desperately needed. Phage therapy, a method where viruses that
lyse speciﬁc bacteria are administered directly to the patient, has been used success-
fully in certain countries, including Russian Federation, Georgia, and Poland, for de-
cades (2). There, they have relied on continual in vitro testing of isolated phages and
clinical isolates. There is now renewed interest globally at the academic and commer-
cial levels, with some recent clinical trials of phage therapy showing promise (3, 4) and
a number of startup companies and larger companies formed around this approach.
Differential phage killing of bacterial cells has been utilized to classify the relatedness
of bacterial strains (called phage typing [5]) for almost 80 years. Despite the clear
applications and potential value of phage killing, many mechanisms and factors
involved in bacterium-phage interactions at the whole-cell level remain to be discov-
ered. As our knowledge of these processes increases, our capacity to utilize this
potential should develop, arguably led by genomic prediction of susceptibility. To this
end, methods that more accurately characterize phage susceptibility or resistance
pathways for sequenced bacterial isolates are needed in order to advance this key ﬁeld.
Phage and bacteria have coevolved for at least 2 billion years in a complex arms race
between the viral predator and the bacterial prey. In terms of the complexity of phage
infection of Gram-negative species, phage are known to interact with outer membrane
protein (OMP) receptors as well as with the lipopolysaccharide (LPS) of the outer
membrane (6), and hundreds of these speciﬁc bacteriophage receptors have been
identiﬁed across different bacterial species (7, 8). After adsorption to the bacterial cell
surface, phage inject their nucleic acid payload, which then leads to complex interac-
tions that result in taking control of the host cells. Lytic phages replicate their genome
primarily by subverting the host replication machinery, followed by further manipula-
tion of protein expression to produce new phage, in a process analogous to those seen
with human/animal viruses. However, phage infection and replication and lysis of the
cell can be prevented through bacterial defense mechanisms. These include clustered
regularly interspaced short palindromic repeats (CRISPR), restriction-modiﬁcation sys-
tems, heterogeneity in expression of surface components, and abortive infection (9).
The complexity of phage-bacterium interactions and the multitude of mechanisms
discovered so far indicate that full-genome screens would likely uncover additional
host genes involved in phage susceptibility.
Previous analysis of genome sequencing data highlighted difﬁculties in elucidating
the genetic determinants of phage susceptibility and resistance directly from the
genome sequence (10, 11). To overcome these difﬁculties, we employed transposon-
directed insertion site sequencing (TraDIS), a method combining phenotypic ﬁtness
selection with genomics to simultaneously assay all genes for their involvement in
survival under selective conditions (12, 13). Using TraDIS, we evaluated all nonessential
chromosomal genes and identiﬁed those involved in susceptibility to Escherichia coli
infection with a speciﬁc T4 phage. This study built on an initial study establishing that
a low-density TraDIS library could be used to conﬁrm the role that the capsule plays in
Salmonella enterica serovar Typhi resistance to the Vi phage (14). Other studies have
also used transposon mutagenesis techniques to investigate phage phenotypes (15–
17) for phages , PAP1, and CbK and largely found associations with LPS or external
structures such as receptors/ﬂagellar antigens that were involved in phage infection
with less emphasis on internal metabolic/resistance operons.
Taking advantage of a phage typing scheme for Shiga-toxigenic E. coli O157 that has
been used at Public Health England (PHE) for over 20 years, we have employed TraDIS
in an assay where we exposed an E. coli O157 high-density transposon library to
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subinhibitory concentrations of a typing phage to which the parent was susceptible.
We then sequenced out from the transposon insertions in the input and recovered
populations to establish a molecular map of E. coli genes impacting host resistance or
susceptibility. The molecular basis for the phage typing scheme has been a mystery
since the start of its use. Thus, we aimed to understand the mechanisms deﬁning lytic
proﬁles of standardized strains to better understand the fundamentals of phage typing
and perhaps why certain phage types (PTs) are found in particular epidemiological
settings. The TraDIS method identiﬁed novel genes which were conﬁrmed individually
as phenotypically controlling phage infection in the host strain. Identifying genes
involved in phage replication will broaden our fundamental understanding of phage
infection processes and ultimately facilitate the design of appropriate phage to target
bacterial pathogens in phage therapy.
RESULTS
Genes involved in phage susceptibility. Genes that inﬂuence phage infection
were identiﬁed by detecting mutants that were not killed as readily by the selecting
phage as was an untreated control (without phage). A total of 114 susceptibility genes,
i.e., genes containing insertions that led to the mutants outcompeting the wild-type
(WT) control and expanding in the population (4-fold increase in the number of
insertions, or log fold change [LogFC]  2) (Fig. 1; see also Table S1 in the supple-
mental material), were identiﬁed. The recognized “susceptibility” genes were either
located as single genes or clustered in operons (Fig. 2).
Under the conditions used, many of the susceptibility genes with the greatest
impact and that had the highest LogFC value had previously been identiﬁed as being
involved in phage infection. For example, the outer membrane protein (OMP) OmpC
and its regulator, OmpR, both showed a dramatic increase in the number of insertions
(9 LogFC) and they both clearly play an important role in susceptibility to this T4
phage. This is to be expected, as OmpC is known to act as a T4 phage receptor without
which infection is far less likely to occur (18).
Interestingly, all genes in the sap (susceptibility to antimicrobial peptides) operon
showed increased numbers of insertions, indicating an expanding mutant population
in the presence of the phage (Fig. 2). Thus, the results have shown that each sap gene
has an effect on the level of phage susceptibility and provide evidence that the entire
operon is involved in phage infection. The sap operon has previously been associated
with resistance to antimicrobial peptides by encoding an ABC transporter to transfer
antimicrobials to the cytoplasm to be degraded (19). It has not yet been associated with
phage infection. Recent work has shown the sap operon to be involved in putrescine
export (20). However, SapD has also been shown to be required for activity of Trk
system potassium uptake proteins TrkA and TrkH (21). Both trkA and trkH also displayed
increased numbers of insertions and were identiﬁed as phage susceptibility genes
(Table S1), suggesting that these systems may interact during the period of phage
susceptibility. sapA has also recently been identiﬁed in playing a role in susceptibility to
antibody-mediated complement-dependent killing (22) which could involve mecha-
nisms similar to those seen in its involvement with phage susceptibility, such as a
general impact on membrane permeability.
One gene (locus identiﬁer [ID] Ecoli9000q_26980), annotated as encoding a hypo-
thetical protein, showed a large and signiﬁcant increase in the number of insertions
compared to the control (LogFC value of 8.48). Its functions were predicted to be
involved in polyribonucleotide nucleotidyltransferase activity using extracted gene
ontology (GO) terms in the EcoCyc database (23). Polyribonucleotide nucleotidyltrans-
ferases are also known as polynucleotide phosphorylases (PNPases) and are widely
conserved in all bacteria. PNPases perform core functions in the cell by regulating
homologous recombination and mismatch repair (24); this could be essential for the
packaging and generation of new phage progeny and the DNA metabolism involved.
Genes involved in phage resistance. We showed that 44 genes had a signiﬁcant
reduction in the number of insertions compared to the control (LogFC value of less
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FIG 1 Volcano plot showing changes in prevalence of mutants in the mutant pool compared to the control during the addition of phage selections,
as shown by the relationship of log2 fold change in selection condition compared to the control (x axis), with the q value (y axis) indicating the
false-discovery rate. Colored points show those genes that pass the cutoff criteria of a 1% false-discovery rate and a log2FC of greater than 2 (green)
or less than 2 (red). Those genes with the highest cutoff criterion results and discussed in the paper are labeled.
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than 2) (Fig. 1; see also Table S2). These genes are likely to play a functional role in
phage resistance, as their inactivation results in cells that are unable to effectively
replicate or are killed more efﬁciently in the presence of T4 phage. Phage resistance
modiﬁers were detected, including stringent starvation protein A and the O antigen
ligase, which had a reduced density of insertions, as the sspA and waaL gene mutants
grew at a rate that was lower (by more than 4-fold) than that seen with the control in
the presence of phage. Genes with the largest reduction in the number of insertions
were mostly involved in outer membrane and replication cellular processes.
Stringent starvation protein A had the largest fold decrease in the number of
insertions compared to the control (LogFC of 9.54), indicating that it likely plays an
important role in the prevention of phage production through transcriptional regula-
tion. Stringent starvation protein A is a global transcriptional regulator that is associ-
ated with RNA polymerase and acts through inhibition of accumulation of H-NS to
upregulate multiple stress defense systems (25). Curiously, it has also been shown to be
essential for expression of bacteriophage P1 late genes (26) but has never been directly
implicated in the infection process.
The 44 resistance genes were found dispersed throughout the chromosome (Fig. 2)
but also exhibited clustering in 4 regions, implicating several key operons in providing
phage resistance. Signiﬁcantly, 7 of the top 10 genes implicated in phage resistance
were found on the O antigen biosynthesis operon (27) (Fig. 2). This operon contained
the O antigen polymerase gene wzy, although the O antigen ligase that showed a
decrease in the number of insertions (LogFC of 5.93) is located on another region of
FIG 2 Brig (36) plot showing the location of 114 genes involved in bacteriophage infection (green arrows) and the 44 genes involved in bacteriophage
resistance (red arrows) on the chromosome of strain 9000. The location of the sap operon is speciﬁed on the chromosome ring, and the names of the genes
and log fold change data for each are represented using EasyFig (37). The location of the O antigen operon is speciﬁed on the chromosome ring, and the names
of the genes and log fold change of each are represented; those genes not implicated in phage resistance are colored white.
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the chromosome. This may indicate that the O antigen itself blocks phage adsorption
in some manner similar to the strategy represented by Salmonella capsule-based
resistance to Vi phage (14). Interestingly, the O antigen ﬂippase wzx gene that is found
on the O antigen biosynthesis operon showed only a small decrease in the number of
insertions (LogFCof 0.04) which was not below the cutoff that deﬁned conﬁdence in
involvement. This means that our cutoff was too stringent to detect its involvement and
that the other genes in the operon showed a decrease in the number of insertions
which a greater conﬁdence could be assigned to. However, the lipid III ﬂippase protein
wzxE gene was found on another part of the chromosome and did show a signiﬁcant
decrease in the number of insertions (LogFC of 3.5).
Conﬁrmation of phenotype conversion with knockout assays. Genes known to
be involved in the synthesis of LPS and extracellular/cell surfaces structures, such as the
susceptibility gene encoding OmpC also identiﬁed here, have long been associated
with phage infection. However, TraDIS has proven to be an extremely sensitive gene
identiﬁcation technique (28, 29) and here, we were able to detect completely novel
genes potentially involved in the phage infection cycle (including both genes confer-
ring resistance and genes conferring susceptibility).
To conﬁrm whether these novel genes implicated in phage infection individually
affected the phage susceptibility/resistance phenotype for all the T4 and T7 phages of
the E. coli O157 typing scheme, a phage plaque-forming assay (see Fig. S1 in the
supplemental material) with deﬁned single-gene knockouts was performed on 6 highly
signiﬁcant gene hits. Three potential resistance gene product mutants were selected to
conﬁrm increased susceptibility: stringent starvation protein A (sspA), O antigen ligase
(waaL), and GDP-L-fucose synthetase (fcl; involved in O antigen biosynthesis [27]).
Similarly, 3 mutants were chosen to test the susceptibility phenotype: a hypothetical
protein (Ecoli9000q_26980), a putrescine ABC exporter membrane protein (sapC), and
a transcriptional activator for formate metabolism operons (fhlA [30]). In this experi-
ment, we predicted that the resistance gene mutants would have increased suscepti-
bility to the E. coli O157 typing phages compared to the parent strain and that the
susceptibility gene mutants would have a greater tolerance than the parent.
Table 1 shows the lytic proﬁles of the knockout strains compared to the wild type
as tested on 14 T4 phages and 2 T7 phages from the E. coli O157 typing scheme (5). The
ability to detect a change in lytic proﬁle was hampered by the degree of difference that
the knockout would garner in comparison to the WT proﬁle. For example, for some of
the typing phages, the WT is already fully lytic, and so any resistance-associated genes
are unlikely to produce an observable phenotype change in plate assays as the strain
cannot become more susceptible than the fully lytic WT. This occurred for typing
phages 3, 7, and 13. Conversely, for one of the typing phages, the WT is already fully
resistant, so any susceptibility-associated genes are unlikely to produce an observable
phenotype change in plate assays as the strain cannot become more resistant than the
WT. This occurred for typing phage 16.
The two mutants associated with O antigens (fcl and waaL) were more susceptible
to all the T4 phages tested (apart from those already fully susceptible plus typing phage
14) and also converted the WT strain to being susceptible to T4 typing phage 16, which
was the only phage it was fully resistant to. The stringent starvation protein A knockout
also caused the T4 phages to become more susceptible than the WT, apart from those
already fully susceptible and typing phage 14. However, the stringent starvation
protein A knockout did not convert the knockout strain to become susceptible to
typing phage 16. Interestingly, the waaL and sspA knockouts had an effect on typing
phage 14 susceptibility that was opposite the predicted effect and the fcl knockout had
an effect on typing phage 3 susceptibility that was the opposite the predicted effect.
The sapC knockout converted the WT to become more resistant to all the T4 typing
phages, apart from typing phage 16, to which was already fully resistant, and typing
phages 8 and 14. The hypothetical protein knockout converted the WT to become more
resistant to all the T4 typing phages, apart from typing phage 16, to which it was
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TABLE 1 Phage plate plaque assay results for typing phages 1 to 16 of the E. coli O157
phage typing scheme (5)a
Resistance associated 
Phage Typing phage WT 1465 Δfcl ΔwaaL ΔsspA Δ Δhypo ΔsapC
T4 
TP1 N 
TP1 10-1 
TP1 10-3 
T4 
TP2 N 
TP2 10-1 
TP2 10-3 
T4 
TP3 N 
TP3 10-1 
TP3 10-3 
T4 
TP4 N 
TP4 10-1 
TP4 10-3 
T4 
TP5 N 
TP5 10-1 
TP5 10-3 
T4 
TP6 N 
TP6 10-1 
TP6 10-3 
T4 
TP7 N 
TP7 10-1 
TP7 10-3 
T4 
TP8 N 
TP8 10-1 
TP8 10-3 
T7 
TP9 N 
TP9 10-1 
TP9 10-3 
T7 
TP10 N 
TP10 10-1 
TP10 10-3 
T4 
TP11 N 
TP11 10-1 
TP11 10-3 
T4 
TP12 N 
TP12 10-1 
TP12 10-3 
T4 
TP13 N 
TP13 10-1 
TP13 10-3 
T4 
TP14 N 
TP14 10-1 
TP14 10-3 
T4 
TP15 N 
TP15 10-1 
TP15 10-3 
T4 
TP16 N 
TP16 10-1 
TP16 10-3 
Clear lysis 
Hazy lysis 
Small amount visible lysis 
No lysis 
Knockout eﬀect 
No change 
Increased lysis = resistance causing gene 
aLevels of lysis in the wild type (WT) are represented by shades of green, with darker colors representing
more-complete levels of lysis, from 5 l of a dilution series of E. coli O157 typing phage 13 (starting with
undiluted phage [N]) spotted onto 1.5% agar plates. The knockout effect is represented by white, red, or
blue squares, where white indicates no change, red indicates increased lysis, and blue indicates decreased
lysis.
Establishing a Genetic Map of E. coli Phage Infection ®
July/August 2018 Volume 9 Issue 4 e00705-18 mbio.asm.org 7
already fully resistant, and typing phages 3, 7, 8, 11, and 12. The fhlA knockout
converted the WT to become more resistant to all the T4 typing phages, apart from
typing phage 16, to which it was already fully resistant, and typing phages 1, 2, 7, 8, and
11. Interestingly, typing phage 8 became more susceptible to all the susceptibility-
associated knockouts that are predicted to convert the strain to being more resistant.
Similarly, the sapC knockout converted the WT to being more susceptible to typing
phage 14, the hypothetical protein knockout converted the WT to being more suscep-
tible to typing phage 4, and the fhlA knockout converted the WT to being more
susceptible to typing phage 7.
The T7 typing phages behaved differently from the T4 typing phages in their lytic
proﬁle changes. Typing phage 9 showed increased lysis for the O antigen fcl gene but
decreased lysis for the other O antigen gene, waaL. However, typing phage 9 did
display the expected decreased lysis for two of the susceptibility-associated knockout
genes, namely, fhlA and the gene encoding a hypothetical protein. On the other hand,
typing phage 10 displayed effects opposite those expected for resistance-associated
genes fcl and waaL as well as for the susceptibility-associated sapC gene. Typing phage
10 is known to speciﬁcally bind the O antigen of E. coli O157 (31), so it is intuitive that
these knockouts would have the countereffect for typing phage 10. Interestingly,
stringent starvation protein A showed no effect on resistance for either of the T7 phage.
DISCUSSION
TraDIS is a genome-wide mutagenesis methodology that has proven useful in
identifying the obvious capsule genes associated with phage susceptibility conversion
(14) as well as with other external structures such as receptors/ﬂagellar/antigens
(15–17). In this study, we optimized the TraDIS method to successfully investigate
bacteriophage-host interactions of lytic T4 and T7 phages and an E. coli O157 strain,
thereby uncovering novel genes involved in phage infection and resistance. One
advantage of this method is that it also enables identiﬁcation of genes conferring
resistance, and therefore we were able to systematically identify genes that normally
hinder phage infection. Several genes involved in E. coli O157 susceptibility and
resistance to T4 and T7 phages were identiﬁed, and a subset of the genes were
conﬁrmed by site-directed deletion, including implication of some in phage interac-
tions for the ﬁrst time. Thus, these data have contributed to a general understanding
of the molecular interactions governing T4 and T7 phage infection of E. coli. Such
fundamental biological information may aid the development of phage therapy as well
as in identifying potential novel bacterial drug targets in the future.
Clearly, phage infection is a complex process involving and relying on a large
number of effector genes that can hinder the process effectively when knocked out.
The dispersed locations of these genes and the involvement of multiple functional
pathways in bacteriophage infection demonstrate that bacteria have evolved a com-
plex and multipronged defense system to protect the cell against phage infection. This
also means that there is a diverse pool of nonobvious genes to investigate for improved
understanding of phage susceptibility.
We were able to identify phage susceptibility genes that showed an increase in the
number of insertions compared to the control. These were genes that are normally
associated with productive phage infection and could be interpreted biologically, as
most encoded outer membrane targets/receptors, which represent the primary point of
phage contact. The gene whose mutant displayed the highest ﬁtness, based on the log
fold change in the number of insertions compared to the control, was ompC. This is an
established receptor for T4 in E. coli (18). Without this gene, mutants could ﬂourish
during phage infection compared to the remainder of the population. OmpC is a
universal OMP in E. coli, and bacteriophage that are able to use it as the primary
receptor generally have a broad host range across E. coli; this interaction does not
always lead to successful lysis, but initial infection and cell adherence are at least
possible if the target bacterial cell has ompC (32). The mutants that also had an
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expanded population during phage exposure included transcriptional regulators ompR
and envZ, which are known to control ompC (33).
The most commonly detected genes from other studies that used transposonmutagen-
esis techniques to examine other phages were those corresponding to phage binding sites,
such as outer membrane substrate transporter genes in E. coli (15), O antigen genes in
Pseudomonas aeruginosa (16), and ﬂagellar genes in Caulobacter crescentus (17). However,
using TraDIS, we could drill more deeply into the full mechanisms of phage susceptibility
and resistance and, in particular, into what happens after successful adsorption. This study
was the ﬁrst of its kind to successfully identify completely novel phage susceptibility/
resistance genes and to conﬁrm them phenotypically using single gene knockouts. Another
signiﬁcant gene of interest (Ecoli9000q_26980) encoded a hypothetical protein which was
implicated in polyribonucleotide nucleotidyltransferase activity. The full phenotype con-
version was conﬁrmed by the knockout plaque assay in half the tested T4 and T7 phage,
conﬁrming an important role in certain examples of phage susceptibility. The importance
of sapC in phage susceptibility was also successfully conﬁrmed phenotypically in 11 of the
16 tested phages. However, we can speculate that other mutations in the sap operon
would reﬂect this phenotype as the TraDIS data implicated the entire sap operon as having
increased numbers of insertions (Fig. 2). The sap operon has previously been associated
with antimicrobial resistance, but this is the ﬁrst time that it has been implicated in phage
susceptibility. The exact mechanism underlying the involvement of this operon in both
bacteriophage infection and antimicrobial resistance requires further investigation.
Novel phage susceptibility genes investigated here included those associated with
infection and efﬁcient lysis speciﬁcally involved in transcription and translation (e.g.,
fhlA). Efﬁcient phage reproduction may require taking over the transcriptional and
translational apparatus of the host cell for phage products. The exact role that these
regulatory genes play in phage infection has yet to be established, but here we established
that a large number of genes were involved in complex multistep processes affecting
the success of phage infection. These gene roles were not proven phenotypically but
demonstrated that, potentially, not all genes identiﬁed by TraDIS would necessarily
show a measurable altered phenotype in a single-gene-knockout assay. This could be
due to functional redundancy that is accounted for by other genes when knocked out.
Many genes showed a decrease in the number of insertions and thus were poten-
tially associated with phage resistance. The gene most signiﬁcantly affected during
bacteriophage infection and which was involved in resistance encoded stringent
starvation protein A. Using an sspA-directed knockout plaque assay, we were able to
conﬁrm that in cells without this gene, the bacteriophage exhibited more-effective
infection in 10 of the 16 phages tested (all of which were T4 phages). This result
contrasts with its reported effects on another phage (34). This raises the interesting
possibility that the genomic landscape of the host may play a role in resistance to some
phages and susceptibility to others. Thus, comprehensive high-throughput studies that
are broader in scope are needed to assess a number of phages and bacterial strains
using the TraDIS method that we developed here to gain a complete atlas of phage
infection processes.
Many of the resistance genes identiﬁed, speciﬁcally, the somatic (O) antigen syn-
thesis genes, are involved in LPS synthesis. This may be expected, as the removal of O
antigens would enable bacteriophage to gain easier access to the OMPs and receptors.
The external surface of a bacterial cell is the ﬁrst point of contact for an infecting
bacteriophage via the outer membrane or LPS. The LPS may be an initial adsorption
target, but LPS O chains might also occlude OMPs. If a cell is able to occlude receptors
by the presence of LPS O chains or some other mechanism, then this could increase
their resistance to phage. Conversely, an insertion that inhibits O antigen production
may result in the mutant becoming more susceptible, as the phage can access
irreversible adsorption sites on OMPs.
To further investigate the function of the proteins encoded by the 6 phenotypically
conﬁrmed genes implicated in phage susceptibility/resistance, we predicted protein func-
tion in silico, using homology comparisons to characterized Pfam domains (shown in
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Table 2). The homology comparisons were performed using an E value of 1.0 and the
multiple-sequence alignments and hidden Markov models (HMMs) of the Pfam database
(35).
The gene encoding the hypothetical protein (Ecoli9000q_26980) was previously
predicted, using gene ontology from the EcoCyc database (23), as having polyribonu-
cleotide nucleotidyltransferase activity. More speciﬁcally, searching the Pfam database
(35) revealed that the gene encoded a protein related to 3= exoribonucleases, polyri-
bonucleotide nucleotidyltransferase (PNPase), showing K homology (present in pro-
teins that bind RNA) and S1 RNA binding capacity. This suggests a potential role in the
nucleotide synthetic activity that phages require for replication of their DNA to package
into new phage progeny. Importantly, PNPases have been shown to be involved in
virulence of E. coli O157 by regulating the expression of Shiga toxin through lambdoid
prophage activation and involvement with phage replication (36). The proven involve-
ment with lambdoid phage replication and the implications of this TraDIS experiment
provide evidence that PNPases are important for T4, T7, and lambdoid phage replica-
tion. Further links of PNPase to virulence reported in E. coli O157 (36) might provide
clarity as to why certain phage types are more commonly associated with severe
infections. The roles of both fcl and waaL in phage resistance were already strongly
predicted to be expressed via the occlusion of OMPs by O antigens (37) using GO term
analysis, through their roles in O antigen biosynthesis, speciﬁcally as a GDP-L-fucose
synthetase and an O antigen ligase, respectively, using our in silico method.
A change in phage resistance was not observed phenotypically for the fhlA knock-
out, which could have been due to regulatory redundancy. However, we were able to
predict a potential functional role for this gene, as protein Pfam domain hits were to the
GAF domain, Sigma-54 interaction, bacterial regulatory protein, and the Fis family.
E. coli phage shock protein F is known to bind Sigma-54 (38). Thus, this transcriptional
activator may be interrupting the phage shock protein pathway that normally protects
the cell and may thereby be acting as a phage susceptibility gene.
The Pfam predictions for the sapC gene were the N-terminal TM domain of oligo-
peptide transport permease C and the binding-protein-dependent transport, inner
membrane component. These results provide further evidence that the Sap operon is
involved in putrescine transport and is likely to be the inner membrane transporter of
phage material into the cell and important in phage susceptibility. The sspA gene had
protein function prediction hits of a glutathione S-transferase (GST). However, it is known
that despite the characteristic fold of GST, SSpA does not have GST activity and cannot bind
glutathione (39). SSpA is known to have a surface-exposed pocket, which suggests that it
mediates protein-protein interactions (39), but its mechanism for phage resistance remains
undetermined, and a more thorough investigation of its function is needed.
As the associated genes recognized to be involved in susceptibility or resistance
were found independently in all four replicates (1-l phage, 200-l phage, and 3-h and
5-h time points), a high conﬁdence can be assigned to them. Now that the TraDIS
method has been successfully validated to identify the drivers of bacteriophage survival
in susceptible strains, the next step would be to use the same method for typing
phages to which the library strain exhibits resistance.
In this study, we have used the TraDIS method to successfully identify several novel
genes involved in maintaining the balance of phage/bacterial survival. This analysis has
shown that bacteriophage susceptibility or resistance involves ﬂuctuating molecular
states that genomic techniques such as TraDIS are able to capture. As the situation
regarding antibiotic resistance becomes increasingly important, we need to investigate
novel methods of killing pathogenic bacteria, and phage therapy holds promise for killing
certain dangerous bacterial species, such as E. coli O157. During this study, a novel gene
involved in phage resistance was identiﬁed, the stringent starvation protein A gene, and the
entire sap operon was implicated in phage infection for the ﬁrst time, providing evidence
for the molecular basis for the E. coli O157 phage typing scheme. Further work identifying
unknown host factors involved in successful phage lysis, or in resistance to it, would be
helpful in the development of phage therapy or novel drug targeting.
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MATERIALS AND METHODS
Producing competent cells of library strain 1465. An E. coli O157 phage type 32 (PT32) Stx2a/Stx2c
knockout of strain 9000 (10) termed strain 1465 was used to produce the library. Two single colonies of
strain 1465 were inoculated into separate 20-ml volumes of lysogeny broths (produced in-house at PHE)
each and left to propagate overnight at 37°C. Each 20-ml overnight culture was added to 300 ml of LB
broth and incubated at 37°C until a mid-log phase (optical density [OD] 0.5) was achieved. The cultures
were then recentrifuged at 3,000 relative centrifugal force (rcf) for 10 min at 4°C in 6 50-ml aliquots.
The supernatant was decanted, and the cells were suspended in 25 ml of ice-cold 10% glycerol. The cells
were centrifuged again at 3,000 rcf for 10 min at 4°C. Subsequently, the supernatant was decanted and
the cells were suspended in 12.5 ml ice-cold 10% glycerol and centrifuged at 3,000 rcf for 10 min at 4°C.
The supernatant was discarded, and the cells were suspended in 6.25 ml ice-cold 10% glycerol. The
supernatant was removed, and the cells were suspended in 0.5 ml of ice-cold 10% glycerol and
centrifuged at 9,000 rpm for 10 min. Finally, the supernatant was removed and the cells were suspended
in 50 l of ice-cold 10% glycerol and kept on ice before electroporation.
Electroporation of transposome into competent cells. A 0.5-l volume of EZ-Tn5 (KAN-2) Tnp
transposome was added to each of the 50-l competent cell aliquots on ice. The mixture of transposome
and competent cells was transferred into 0.1-cm-path-length electroporation cuvettes and electropo-
rated (with settings of 1.4 kV, 25 F, and 200 ) in a Gene Pulser Xcell electroporation system (Bio-Rad).
Cells were immediately recovered in 1 ml of Super Optimal Broth with catabolite repression (Life
Technologies) after electroporation. This was repeated for each of the 6 aliquots of competent cells. The
recovered cells were then incubated for 2 h at 37°C in a shaking incubator.
We have conﬁdence that our Tn5 transposon inserts in an unbiased manner; the manufacturer’s
instructions of the Epicentre Tn5 transposon kit used (http://www.epibio.com/docs/default-source/protocols/
ez-tn5-transposase.pdf?sfvrsn4) state that the Tn5 should insert randomly, and although Tn5 trans-
posons are traditionally thought to have a slight AT preference, they have been shown to unbiasedly
saturate E. coli chromosomes overall (40). We are conﬁdent that all genes of greater than ~600 bp and
containing 1 insertion every 47 bp would be assayed with our method. There is an extremely low (0.1%)
random chance of a gene of an ~600-bp gene not containing any transposons, if nonessential (as ﬁrst
estimated previously [12]), and because we used duplicate cultures, this probability decreases to almost
zero. Thus, we believe we have achieved insertions in, and thus can assay, all nonessential genes.
Recovery of transformed cells. Transposon-containing colonies were recovered from each of the 6
electroporated cultures on lysogeny broth plates containing kanamycin (4 mg/liter) and incubated
overnight at 37°C. Colonies of transformed cells were counted and harvested and then stored at 80°C
in a ﬁnal concentration of 20% glycerol after the optical density (OD) had been recorded for that batch.
This method was repeated 30 times to produce 30 different batches, and 1,000,000 mutant colonies
were harvested. Batches were pooled in an equimolar manner according to the OD at 600 nm (OD600)
in the ﬁnal library.
TraDIS sequencing and library density. TraDIS-speciﬁc sequencing was performed on a HiSeq 2500
machine using 50-bp single-end reads to produce transposon-directed reads as described previously
(41). To determine that insertion sites of each transposon that had randomly inserted into the genome
of each mutant, a TraDIS library was prepared using speciﬁcally designed TraDIS adapters for the Tn5
transposon (see Table S3 in the supplemental material). This method increased the enrichment of
genuine transposon-chromosome junctions by preventing hybridization of the reverse primer until the
transposon-speciﬁc forward primer had generated a complementary strand (41). This ensured that the
ﬁrst 10 bp of every read consisted of transposon sequence and that the remaining sequence was
downstream of where the transposon was inserted. These reads were then mapped using SMALT (WTSI),
and insertion quantiﬁcation was performed by the use of a PacBio-sequenced reference for strain 9000
(RefSeq accession number NZ_CP018252) to determine the location of the transposon insertions. The
reference strain was annotated with Prokka (42) to identify the genes in the insertions were found. Genes
essential for survival, which are unable to tolerate any transposon insertions as deﬁned by having less
than 10 reads mapped per gene without selection, are not measurable with TraDIS and were thus not
assayed in this study. Analysis of the sequencing data showed that the library had 110,000 unique
transposon insertion sites throughout the genome with a density of one insertion for every 47 bp of the
genome, providing multiple unique insertions in every viable gene and functionally signiﬁcant noncod-
ing regions. The multiple sites in each locus together act as independent indicators (similarly to
“biological replicates”) (43).
Bacteriophage selections on library. The library was interrogated with T4 bacteriophage 13 of the
typing phages (5), which was fully lytic when exposed to E. coli O157 PT32 strain 1465. A pool of the
library was cultured overnight, with 106 cells added to 10 ml of LB broth. Following incubation for 18 h,
100 l of the library was inoculated into 10 ml of LB broth and allowed to propagate to mid-log phase.
A 100-l volume of the log phase culture was then inoculated into three 10-ml aliquots of LB broth. Then,
10 l and 200 l (multiplicity of infection, ~10) of bacteriophage were inoculated into two of the broths
and into one used as a control that was prepared without bacteriophage selection but cultured in parallel
under the same conditions. DNA extractions were taken at both the 3-h and 5-h time points using a
Wizard genomic extraction kit (Promega). DNA extractions for the controls and the selections were used
for TraDIS-speciﬁc sequencing (see Table 3) on a HiSeq 2500 platform, generating 14.6 million reads
(reads per sample detailed in Table 3). The sequences from all samples were submitted to the European
nucleotide archive (ENA).
Bioinformatics analysis. Transposon-directed sequencing reads had transposon tags removed and
were then mapped to the genome sequence (sequenced using PacBio technology) of strain 9000 (10)
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(see Table 3). A change in the number of reads that mapped to each gene between the control and the
selections was measured using LogFC (log2 fold change), calculated from log counts per million using
in-house TraDIS analysis scripts (https://github.com/sanger-pathogens/Bio-Tradis) (41). This approach
automatically determines appropriate read mapping parameters from the length of the ﬁrst read in the
fastq ﬁle. LogFC was used as a measure of comparison of fold changes in read numbers compared to the
LB control; 2 and 2 were used as cutoff values for genes with different numbers of insertions (41).
False-positivity (P) and false-discovery (q) values were given for each calculation as a measure of
statistical signiﬁcance in terms of the P and q rates (44). Only those that had a q value of 0.01 and a
P value of 0.05 were included (see Fig. 1). The data determined for those genes that were implicated
independently in all four replicates (10 l phage, 200 l phage, and 3-h and 5-h time points) were
averaged for the two concentrations to give a consensus list of the genes involved in phage susceptibility
and resistance that were present at both time points and both concentrations.
Gene deletion. Deletion of individual genes was achieved by replacing the target genes with a
chloramphenicol (Cm) acetyl transferase (cat) cassette using the standard Lambda Red-mediated gene
replacement method (45). Brieﬂy, the cat cassette was ampliﬁed directly from template plasmid pKD3
using the gene knockout primers described in Table S4. The PCR products (~1 kb) were subjected to
agarose gel puriﬁcation and transformed by electroporation into E. coli strains carrying helper plasmid
pKD46. The chloramphenicol-resistant (Cmr) transformants were selected on LB agar plates containing
25 g ml1 of Cm. The deletion mutants were veriﬁed by colony PCR using an upstream primer of the
target genes with C1, a primer that anneals in the cat cassette (Table S4). These PCR products were then
sequenced to conﬁrm the insertion of the cat cassette in the correct location.
Phage plate plaque assays. The parent strain (ZAP1465) and each of the deletion mutants were
cultured in liquid LB until an OD600 of ~1.0 was reached. A 250-l volume of culture was added to 3 ml
of molten top agar and poured on top of an LB agar plate. Once set, 5 l of a dilution series (starting
with undiluted phage) of E. coli O157 typing phages 1 to 16 was spotted onto the plates in the manner
shown in Fig. S1 in the supplemental material. The plates were incubated overnight at 37°C and then
photographed to show lysis proﬁles, and the results are summarized in Table 1.
Accession number(s). The sequences from all samples were submitted to the European nucleotide
archive (ENA), and accession numbers are given in Table 3.
SUPPLEMENTAL MATERIAL
Supplemental material for this article may be found at https://doi.org/10.1128/mBio
.00705-18.
FIG S1, DOCX ﬁle, 0.8 MB.
TABLE S1, DOCX ﬁle, 0.1 MB.
TABLE S2, DOCX ﬁle, 0.1 MB.
TABLE S3, DOCX ﬁle, 0.05 MB.
TABLE S4, DOCX ﬁle, 0.1 MB.
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